All Stories

Viracta Therapeutics hits end of the line, laying off all workers and winding down

Cancer biotech Viracta Therapeutics has closed its doors, laying off all employees and winding down operations.

Feb 9, 2025 - 22:25
 0
Viracta Therapeutics hits end of the line, laying off all workers and winding down
Cancer biotech Viracta Therapeutics has closed its doors, laying off all employees and winding down operations.
Read More

Tags:

Previous Article

UPDATED: Eli Lilly lops Alzheimer's and obesity assets from pipeline in Q4 update

Next Article

Denali eyes approval after Hunter syndrome drug clears safety measures, reduces ...

Related Posts

Sanofi takes $250M hit after gamble on J&J E. coli vaccine ends in phase 3 failure

Sanofi takes $250M hit after gamble on J&J E. coli vacc...

Feb 13, 2025  0

Corbus posts first US data on challenger to Pfizer's ADC Padcev

Corbus posts first US data on challenger to Pfizer's AD...

Feb 17, 2025  0

VC firm Kineticos launches biotech to develop fresh approach to antibiotic resistance

VC firm Kineticos launches biotech to develop fresh app...

Feb 24, 2025  0